Research on Essential Medicine Shortages in Botswana’s Public Sector
Title: A Multi-Level, Multi-Dimensional Integrated Investigation of the Primary Causes of Essential Medicine Shortages in the Botswana Public Sector: Stakeholder Analysis, Impact, and Mitigation Strategies
Project Overview: The research project aimed to investigate the primary causes of essential medicine shortages in Botswana’s public healthcare system, along with the associated impacts and potential mitigation strategies. Recognizing the critical role of essential medicines in treating diseases and improving health outcomes, the study sought to address a gap in Botswana’s healthcare system, where limited contextual data existed on the causes and solutions for these shortages.
The study applied a multidimensional, multilevel methodological framework combining both qualitative and quantitative approaches. This included stakeholder analysis, questionnaire surveys, and semi-structured key informant interviews. A combination of purposeful sampling for interviews and stratified random sampling for the survey allowed comprehensive data collection from diverse stakeholders within Botswana’s pharmaceutical system, including regulatory agencies, pharmaceutical manufacturers, distributors, and healthcare providers.
Key Findings: The research successfully identified and analyzed the primary causes of medicine shortages, such as regulatory challenges, parallel trade, economic decisions to suspend or discontinue production, and inefficiencies in the supply chain. The impact of these shortages on healthcare delivery was explored, highlighting how patients’ access to essential treatments was affected, particularly in underserved areas.
Mitigation Strategies: The research also proposed practical mitigation strategies aimed at improving the reliability and accessibility of essential medicines. This included recommendations for strengthening the pharmaceutical supply chain, enhancing coordination among stakeholders, and implementing regulatory reforms.
Outcome and Contribution: The completed research provided valuable insights into Botswana’s public healthcare sector and contributed to strengthening the country’s pharmaceutical system. The findings and proposed solutions are expected to inform future policy decisions and initiatives aimed at improving the supply and accessibility of essential medicines, ultimately benefiting patient care and health outcomes across the nation.